mCRPC patients receiving 225Ac-PSMA-617 therapy in the post-androgen deprivation therapy setting : response to treatment and survival analysis

Sathekge, Mike Machaba; Bruchertseifer, Frank; Vorster, Mariza; Lawal, Ismaheel Opeyemi; Knoesen, Otto; Mahapane, Johncy; Davis, Cindy; Mdlophane, Amanda; Maes, Alex; Mokoala, Kgomotso M.G.; Mathabe, Kgomotso; Van de Wiele, Christophe; Morgenstern, Alfred

dc.contributor.author	Sathekge, Mike Machaba
dc.contributor.author	Bruchertseifer, Frank
dc.contributor.author	Vorster, Mariza
dc.contributor.author	Lawal, Ismaheel Opeyemi
dc.contributor.author	Knoesen, Otto
dc.contributor.author	Mahapane, Johncy
dc.contributor.author	Davis, Cindy
dc.contributor.author	Mdlophane, Amanda
dc.contributor.author	Maes, Alex
dc.contributor.author	Mokoala, Kgomotso M.G.
dc.contributor.author	Mathabe, Kgomotso
dc.contributor.author	Van de Wiele, Christophe
dc.contributor.author	Morgenstern, Alfred
dc.date.accessioned	2023-07-26T06:50:21Z
dc.date.available	2023-07-26T06:50:21Z
dc.date.issued	2022-10
dc.description.abstract	Please read abstract in the article.	en_US
dc.description.department	Nuclear Medicine	en_US
dc.description.librarian	hj2023	en_US
dc.description.uri	http://jnm.snmjournals.org	en_US
dc.identifier.citation	Sathekge, M., Bruchertseifer, F., Vorster, M., Lawal, I.O., Knoesen, O., Mahapane, J., Davis, C., Mdlophane, A., Maes, A., Mokoala, K., Mathabe, K., Van de Wiele, C. & Morgenstern, A. 2022, 'mCRPC patients receiving 225Ac-PSMA-617 therapy in the post-androgen deprivation therapy setting: response to treatment and survival analysis', Journal of Nuclear Medicine, vol. 63, no. 10, pp. 1496-1502, doi : 10.2967/jnumed.121.263618.	en_US
dc.identifier.issn	0161-5505 (print)
dc.identifier.issn	2159-662X (online)
dc.identifier.other	10.2967/jnumed.121.263618
dc.identifier.uri	http://hdl.handle.net/2263/91638
dc.language.iso	en	en_US
dc.publisher	Society of Nuclear Medicine	en_US
dc.rights	© 2022 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY).	en_US
dc.subject	225Ac-PSMA-617	en_US
dc.subject	Prostate specific membrane antigen (PSMA)	en_US
dc.subject	Metastatic castration-resistant prostate cancer (mCRPC)	en_US
dc.subject	Androgen deprivation treatment (ADT)	en_US
dc.subject	Therapy response	en_US
dc.subject	PSA response	en_US
dc.subject	Prostate carcinoma	en_US
dc.subject	Prostate specific antigen (PSA)	en_US
dc.subject	SDG-03: Good health and well-being	en_US
dc.title	mCRPC patients receiving 225Ac-PSMA-617 therapy in the post-androgen deprivation therapy setting : response to treatment and survival analysis	en_US
dc.type	Article	en_US